Better Therapeutics, Inc.
BTTX · OTC
9/30/2023 | 6/30/2023 | 3/31/2023 | 12/31/2022 | |
|---|---|---|---|---|
| Market Cap | $14,089 | $33,712 | $16,679 | $26,357 |
| - Cash | $6,598 | $6,196 | $6,068 | $15,740 |
| + Debt | $14,307 | $14,212 | $14,540 | $14,880 |
| Enterprise Value | $21,798 | $41,728 | $25,151 | $25,497 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | -$841 | -$797 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$4,500 | -$6,228 | -$8,170 | -$7,601 |
| % Margin | – | – | – | – |
| Net Income | -$5,862 | -$7,589 | -$9,357 | -$8,765 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.15 | -0.24 | -0.39 | -0.37 |
| % Growth | 37.5% | 38.5% | -5.4% | – |
| Operating Cash Flow | -$5,943 | -$5,087 | -$8,716 | -$6,337 |
| Capital Expenditures | -$5 | -$503 | -$521 | -$360 |
| Free Cash Flow | -$5,948 | -$5,590 | -$9,237 | -$6,697 |